Literature DB >> 12703968

Model studies on protein side chain modification by 4-oxo-2-nonenal.

Wei-Han Zhang1, Jiyun Liu, Guozhang Xu, Quan Yuan, Lawrence M Sayre.   

Abstract

trans-4-Oxo-2-nonenal (ONE) has recently been demonstrated to be a direct product of lipid peroxidation. In earlier studies to elucidate the structure of the trans-4-hydroxy-2-nonenal (HNE)-derived fluorescent Lys-Lys cross-link, we showed that ONE was capable of both oxidative and nonoxidative cross-linking of amines. A more comprehensive study on nonoxidative modification of protein nucleophiles by ONE is described here, focusing on the initial Michael addition of imidazole, thiol, and amine groups to C2 or C3 to give 4-keto aldehydes that can then condense with amines to form nucleophile-substituted pyrroles. 2,3-Substituted pyrroles (major) and 2,4-substituted pyrroles (minor) were distinguished by 2D NMR techniques, and N(tau)-substitution is preferred over N(pi)-substitution in the Michael addition of histidine. Mechanisms of both nonoxidative and oxidative side chain reactions of ONE are discussed, as is the relative propensity (ONE > HNE) to induce cross-linking of the model proteins ribonuclease A and beta-lactoglobulin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12703968     DOI: 10.1021/tx020105a

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  37 in total

1.  N-terminal valine adduct from the anti-HIV drug abacavir in rat haemoglobin as evidence for abacavir metabolism to a reactive aldehyde in vivo.

Authors:  C Charneira; N M Grilo; S A Pereira; A L A Godinho; E C Monteiro; M M Marques; A M M Antunes
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 2.  Protein damage by reactive electrophiles: targets and consequences.

Authors:  Daniel C Liebler
Journal:  Chem Res Toxicol       Date:  2007-12-04       Impact factor: 3.739

3.  Conformational interconversion of the trans-4-hydroxynonenal-derived (6S,8R,11S) 1,N(2)-deoxyguanosine adduct when mismatched with deoxyadenosine in DNA.

Authors:  Hai Huang; Hao Wang; R Stephen Lloyd; Carmelo J Rizzo; Michael P Stone
Journal:  Chem Res Toxicol       Date:  2009-01       Impact factor: 3.739

Review 4.  Oxidative stress and covalent modification of protein with bioactive aldehydes.

Authors:  Paul A Grimsrud; Hongwei Xie; Timothy J Griffin; David A Bernlohr
Journal:  J Biol Chem       Date:  2008-04-29       Impact factor: 5.157

5.  Partial characterization of the molecular nature of collagen-linked fluorescence: role of diabetes and end-stage renal disease.

Authors:  David R Sell; Ina Nemet; Vincent M Monnier
Journal:  Arch Biochem Biophys       Date:  2009-10-30       Impact factor: 4.013

Review 6.  Signaling actions of electrophiles: anti-inflammatory therapeutic candidates.

Authors:  Alison L Groeger; Bruce A Freeman
Journal:  Mol Interv       Date:  2010-02

7.  Methyl-methoxylpyrrolinone and flavinium nucleus binding signatures on falcipain-2 active site.

Authors:  Olaposi I Omotuyi
Journal:  J Mol Model       Date:  2014-08-06       Impact factor: 1.810

8.  Charge-derivatized amino acids facilitate model studies on protein side-chain modifications by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Xiaochun Zhu; Vernon E Anderson; Lawrence M Sayre
Journal:  Rapid Commun Mass Spectrom       Date:  2009-07       Impact factor: 2.419

9.  The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells.

Authors:  Hyun-Pil Lee; Xiaochun Zhu; Xiongwei Zhu; S Chad Skidmore; George Perry; Lawrence M Sayre; Mark A Smith; Hyoung-Gon Lee
Journal:  J Neurochem       Date:  2009-01-13       Impact factor: 5.372

10.  Effects of Lipid Peroxidation-Derived Products on the Growth of Human Colorectal Cancer Cell Line HT-29.

Authors:  Satoru Sakuma; Hiromi Sumi; Tetsuya Kohda; Yukio Arakawa; Yohko Fujimoto
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.